Reactivity of monoclonal antibodies with ganglioside antigens in human small cell lung cancer tissues

This publication has 11 references indexed in Scilit:

• Anti-melanoma effects of R24, a monoclonal antibody against GD3 ganglioside
  Melanoma Research, 1997
• Phase Ia/Ib Trial of Anti-GD2 Chimeric Monoclonal Antibody 14.18 (ch l4.18) and Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (rhGM-CSF) in Metastatic Melanoma
  Journal of Immunotherapy, 1996
• Small Cell Lung Cancer
  Chest, 1995
• Coexpression of Ganglioside Antigen Fuc-GM1, Neural-Cell Adhesion Molecule, Carcinoembryonic Antigen, and Carbohydrate Tumor-Associated Antigen CA 50 in Lung Cancer
  Tumor Biology, 1992
• Immunohistochemical detection of two small cell lung carcinoma‐associated antigens defined by MAbs F12 and 123C3 in bronchoscopy biopsy tissues
  APMIS, 1991
• GD3 expression by cultured human tumor cells of neuroectodermal origin
  Acta Neuropathologica, 1989
• Binding specificity of monoclonal antibodies to ganglioside, Fuc-GM1
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986
• Fucosyl-GM1 — A ganglioside associated with small cell lung carcinomas
  Glycoconjugate Journal, 1984
• Identification of a human neuroectodermal tumor antigen (OFA-I-2) as ganglioside GD2.
  Proceedings of the National Academy of Sciences, 1982
• GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody.
  The Journal of Experimental Medicine, 1982